The global rotator cuff injury treatment market is projected to reach USD 1,244 million by 2026 from USD 989 million in 2021, at a CAGR of 4.7% during the forecast period. Rising number of sports-related shoulder injuries, technological advancements in rotator cuff rupture devices, greater product affordability and market availability, and growing public awareness related to the availability of different treatments for rotator cuff rupture. Additionally, developments in regenerative biologics are likely to offer significant growth opportunities for players in the rotator cuff injury treatment market
Some of the prominent players operating in global rotator cuff injury treatment includes Arthrex (US), Stryker Corporation (US), Smith & Nephew (UK), Johnson & Johnson (DePuy Synthes) (US), Zimmer Biomet (US), CONMED Corporation (US), Integra LifeSciences (US), LimaCorporate (Italy), FH ORTHOPEDICS S.A.S. (France), Evolutis India Pvt. Ltd. (India), DJO Global (US), 3S Ortho (France), Breg, Inc. (US), GPC Medical Ltd. (India), and Parcus Medical (US).
To know about the assumptions considered for the study download the pdf brochure
The analysis of market developments between 2018 and 2021 revealed that several growth strategies such as research collaborations and partnerships were adopted by market players to strengthen their product portfolios and maintain a competitive position in the rotator cuff injury treatment market
Smith & Nephew
Smith & Nephew is one of the leading global producers of advanced wound management, arthroscopy, trauma and clinical therapy, and orthopedic reconstruction products. The company operates in more than 100 countries across the Americas, Africa, Asia, Australasia, Europe, and the Middle East. The company’s geographic presence is divided into established and emerging markets, where the established markets consist of the US, Canada, Australia, Europe, Japan, and New Zealand. The company has an advanced integrated deep global distribution network in the shoulder arthroscopic product category. The establishment of a direct sales model has accelerated the Smith & Nephew product platform strategy, firming the company’s position in the orthopedics space. The successful execution of clinical trials for Regeneten, a bioinductive collagen for rotator cuff tear, and receiving the CE mark approval in Europe, the company has enhanced its capabilities in developing biologics for rotator cuff tear treatment.
Arthrex is a German-based medical device company that is engaged in the development and manufacture of the shoulder, knee, elbow, hand & wrist, foot & ankle, hip, and related products, orthobiologics, and imaging & resection products. The company commercializes its products directly and through a wide network of distributors in the Americas, Europe, the Middle East, Africa, and Asia. Arthrex is headquartered in Naples, Florida, the US. With the successful launch of the shoulder arthroscopy system in the US, the company strengthened its geographical footprint across North America, further increasing its customer base by offering advanced treatment options to patients undergoing treatment for rotator cuff tears. The company emphasizes on strengthening its supply and distribution channel across the globe through distribution agreements. Recent acquisitions and partnerships with manufacturers engaged in the development of orthobiologics have offered a great opportunity for the company to enlarge its product portfolio and pipeline for the rotator cuff tear treatment market.
Stryker Corporation is one of the leading providers of highly innovative medical products and services in orthopedics, medical and surgical, and neurotechnology and spine fields. The company is adopting various organic and inorganic growth strategies to maintain its position in the market. Acquisitions, the continuous launch of innovative products for rotator cuff tear treatment, and participation in national and international conferences offer growth opportunities for the company to enhance its brand presence across the globe. Successful clinical trial results and recent approval from the FDA for new products such as InSpace, which is a minimally invasive biodegradable for arthroscopic treatment of massive, irreparable rotator cuff tears, has resulted in the increased adoption of the company’s products among orthopedic surgeons. Stryker has built a strong direct distribution network in the domestic market, commercializing its products directly to hospitals and other healthcare facilities. The company has a large network of international distributors in over 100 countries through company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. Through this, the company is likely to increase its customer base worldwide.
Zimmer Biomet is involved in the development, manufacturing, and commercialization of a wide range of surgical products for musculoskeletal health, such as orthopedic reconstructive products, dental implants, craniomaxillofacial and thoracic products (CMFT), and other related products to support bone, joint-associated disorders, and injuries. Zimmer Biomet has a strong geographical presence with a direct distribution network in the Americas, EMEA (Europe, the Middle East, and Africa), and the Asia Pacific. Zimmer Biomet has strong sales channels with business operations in more than 25 countries across the globe and commercializes products in over 100 countries across the globe. Zimmer Biomet focuses on adopting inorganic growth strategies through continuously engaging in mergers and acquisitions, further strengthening its product portfolio.
Johnson & Johnson (DePuy Synthes)
Johnson & Johnson commercializes its wide range of orthopedic medical devices and MedTech solutions through its subsidiary DePuy Synthes. The company offers products for various domains, including orthopedics and neurology and services for joint reconstruction, spine, trauma, neuro, craniomaxillofacial, spinal surgery, and sports medicine. The company continuously focuses on new product developments and the launch of innovatively designed suture anchors for the repair of the rotator cuff. This offers tremendous opportunities for the company to strengthen its product portfolio in the rotator cuff tear treatment market and expand its geographic footprint. Strategic investments in key products and systems designed for minimally invasive rotator cuff repair procedures help the company to increase the commercialization of its products. The company focuses on participating in various scientific events and forums to remain informed about the latest advances in scientific and sports medicine research, increasing its capabilities in building a strong product portfolio.
Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) -Global Forecast to 2026
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE